|
Descriptive statistics for the heart failure cohort |
||
| Variable |
N |
Mean ± SD |
|
|
||
| Age at onset of heart failure (yrs) |
655 |
53.79 ± 12.73 |
| Follow-up time (yrs) |
655 |
3.16 ± 2.70 |
| Height (cm) |
554 |
172.2 ± 10.06 |
| Weight (kg) |
560 |
85.82 ± 20.73 |
| Left Ventricular Ejection Fraction |
415 |
27.72 ± 13.72 |
| Left Ventricular Mass indexed to Body Surface Area |
456 |
189.14 ± 69.04 |
| Fractional Shortening |
492 |
21.97 ± 11.16 |
| Variable |
N |
% |
|
|
||
| Males |
453 |
69.2 |
| Hypertension |
310 |
47.9 |
| Beta Blocker Use |
455 |
69.6 |
| ACE Inhibitor Use |
550 |
84.0 |
| Had Endpoint: |
||
| Death |
127 |
19.4 |
| Cardiac Transplant |
171 |
26.1 |
| Heart Failure Etiology: |
||
| Dilated Cardiomyopathy |
382 |
58.3 |
| Ischemic Cardiomyopathy |
259 |
39.5 |
| Other |
14 |
2.1 |
Kardia et al. BMC Medical Genetics 2008 9:93 doi:10.1186/1471-2350-9-93 |
||